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ABSTRACT 
In order to evaluate the role of ethyl acetate fraction (PB-EtAC) obtained from the Phyllosta-
chys bambusoides leaves in the modulation of immune responses, detailed studies were car-
ried out using a panel of in vivo assays. Oral administration of PB-EtAC (50–200 mg/Kg) 
stimulated the IgM and IgG titre expressed in the form of haemagglutination antibody (HA) 
titre. Further, it elicited a dose related increase in the delayed type hypersensitivity reaction 
(DTH) after 24 and 48 h in BALB/c mice. Besides augmenting the humoral and cell mediated 
immune response, the concentration of cytokines (IFN-γ, IL-2, and IL-4) in serum with re-
spect to T cell interactions also increased significantly. It also induced macrophage phagocy-
tosis, and nitric oxide (NO) production which resulted in a high degree of protection against 
Candida albicans and carbon clearance. Moreover, the enhancement in CD4 and CD8 cell 
populations as revealed by flow cytometry. Taken together this in vivo and ex vivo preclinical 
data, our results suggested that PB-EtAC acts as an effective immunostimulator eliciting both 
Th1 and Th2 immune responses. We are reporting first time the immunostimulatory potential 
of P. bambusoides and it might be regarded as a biological response modifier. 
 
Keywords: Haemagglutination antibody titre, delayed type hypersensitivity reaction, phago-
cytosis, nitric oxide, Candida albicans, flow cytometry 
 
 
 
INTRODUCTION 
Immunomodulation using medicinal 
plants can provide an alternative to conven-
tional chemotherapy for a variety of diseas-
es, especially when host defense mecha-
nism has to be activated under the condi-
tions of impaired immune response or when 
a selective immunosuppression is desired in 
situations like autoimmune disorders. In 
order to regulate the normal immunological 
functioning both immunostimulation and 
immunosuppression need to be tackled. 
Hence both immunosuppressing agents and 
immunostimulating agents have their own 
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standing and search for better molecules 
exerting these activities is becoming the 
field of major interest all over the Earth 
(Patwardhan et al., 1990). 
Traditional Indian system of medicine 
like Siddha and Ayurveda have suggested 
means to increase the body’s natural re-
sistance to disease. A large number of Indi-
an medicinal plants and various ‘Rasaya-
nas’ have been claimed to possess im-
munomodulatory activity (Atal et al., 
1986).  
Phyllostachys bambusoides (bamboo) is 
a giant, woody grass distributed tropically 
and subtropically, and represents an im-
portant commodity. It is used as building 
material, food material, handicraft article 
and traditional medicine. It has mainly been 
used as a clinical Chinese traditional medi-
cine to cure stomach-ache, diarrhoea or 
vomiting, chest diaphragm inflammation, 
restlessness and excessive thirst, and its ef-
ficacy had been recorded in the material 
medica of past dynasties in Chinese history 
(Zhang et al., 2004). Recently, their poten-
tial health benefits and some biologically 
active components have been widely stud-
ied (Lu et al., 2005). It is already reported 
to possess number of therapeutic uses in-
cluding reduction in allergic response (Kim 
et al., 2012), antioxidants (Mu et al., 2004), 
antipyretic, analgesic as well as anticonvul-
sant (Kumar et al., 2011). In recent time, 
focus on plant research has been intensified 
all over the world and a large number of 
evidence has been collected to show im-
mense potential of medicinal plants used in 
various traditional system of medicine 
(Ponnuswamy and Devairrakam, 2011). 
The principal nutrients thought to provide 
the protection afforded by leaves are anti-
oxidants such as vitamin C, vitamin E, gly-
cosides and flavonoids (including flavones, 
isoflavones, and anthocyanins). Convincing 
phytochemical research studies show that 
bamboo is a good source of flavonoids and 
glycosides that are a rich source of power-
ful antioxidants. The immune-stimulatory 
potential of P. bambusoides on immune 
system has not yet been explored. There-
fore, the objective of the present study was 
evaluation of immunostimulatory potential 
of ethyl acetate fraction (PB-EtAC) from P. 
bambusoides against SRBC in BALB/c 
mice. In this attempt, the effects of PB-
EtAC on humoral immunity keeping neu-
tralizing antibodies in mind, cellular im-
mune responses via delayed type hypersen-
sitivity reaction, lymphocyte proliferation, 
macrophage phagocytosis, release of NO by 
the activated macrophages, cytokine profile 
and co-stimulatory molecules were investi-
gated. 
 
MATERIALS AND METHODS 
Materials 
Ethyl acetate fraction (PB-EtAC) of al-
coholic extract of the plant P. bambusoides 
was used in this study. The leaves of P. 
bambusoides were collected from the fields 
of University of Horticulture and Forestry, 
Nauni, Solan, India in July 2012. A voucher 
specimen (UHF/12530) has been deposited 
in the Herbarium Section of Department 
Forestry, Nauni University. Methanol was 
purchased from Qualigens, Mumbai, medi-
um RPMI 1640 (Himedia, Bombay, India), 
96 V wells microtitration plates and mi-
crotissue culture plates (96 U wells) from 
Tarson, trypan blue (Microlabs, Bombay), 
fetal calf serum (FCS) (Gibco, USA), 
Concanavalin-A (Con-A), lipopolysaccha-
ride (LPS), gum acacia, dimethylsulphoxide 
(DMSO), penicillin, streptomycin, MTT (3-
[(4,5-dimethylthiazol-2yl)-2,5-diphenyltetra-
zolium bromide) and levamisole from Sig-
ma were used.  
 
Preparation of ethyl acetate fraction 
The powdered plant material (750 g) 
was subjected to percolation process with 
90 % methanol at room temperature. After 
exhaustive extraction, the methanolic ex-
tract (PB-EtAC) was concentrated under 
reduced pressure at 50–55 °C. Extract was 
adsorbed with silica and subjected to frac-
tionation with various solvents like petrole-
um ether, chloroform and ethyl acetate. For 
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pharmacological studies, a weighed amount 
of ethyl acetate fraction was suspended in a 
1 % (w/v) aqueous acacia solution. 
 
HPLC fingerprinting of the extract 
HPLC fingerprinting of the PB-EtAC 
was developed as described earlier (Wang 
et al., 2012). The separation was carried out 
on an Agilent 1200 series (USA), Eclips 
XBD C18 column, 4.6 × 150 mm, 5 µm 
particle sizes, and the temperature was 
maintained at 25 °C. Then, 25 µL of sample 
was injected into the column and eluted 
with a constant rate of 1.0 mL/min. HPLC-
grade water with 0.5 % (v/v) glacial acetic 
acid and acetonitrile (85/15, v/v) were used 
as mobile phase in 85:15 ratio. The absorb-
ance detector was operated at 345 nm.  
 
Animals 
The study was conducted on four to six 
week old male Balb/c mice (18-22 g). The 
ethical committee of the Indian Institute of 
Integrative Medicine (CSIR) instituted for 
animal handling approved all protocols. 
The animals were bred and maintained un-
der standard laboratory conditions: temper-
ature (25 ± 2 °C) and photoperiod of 12 h. 
Commercial pellet diet (Ashirwad Indus-
tries, Chandigarh, India) and water were 
given ad libitum. According to ethical regu-
lations on animal research, all animals used 
in experimental work received human care. 
 
Acute toxicity  
Different doses (5-2000 mg/Kg, oral) of 
PB-EtAC were administered to groups of 
mice (6 in each group). The animals were 
continuously observed for 2 h to detect 
changes in the autonomic or behavioural 
responses. Mortality in each group was ob-
served for 7 days. The doses of 50, 100 and 
200 mg/Kg were selected based on the re-
sults of preliminary toxicity testing. 
 
Immunization schedule 
Sheep red blood cells (SRBC) were 
used as a source of T-dependent antigen. 
For this purpose, the blood was withdrawn 
from a healthy sheep in Alsever's solution 
(Alsever and Ainslie, 1941). SRBC used for 
immunization were prepared in pyrogen-
free normal saline. Mice were divided into 
five groups, each consisted of six animals. 
PB-EtAC at 50, 100 and 200 mg/Kg (in 
200 μL of 1 % gum acacia) was adminis-
tered orally by gavage for 14 days, daily. 
The dose volume was 0.2 mL. Control 
group received 1 % gum acacia. Levami-
sole, a known immune-stimulator reported 
to augment the antibody response (Tempero 
et al., 1995), was given orally as positive 
control, at a dose of 2.5 mg/Kg body 
weight. All groups were immunized with 
0.2 mL of SRBC (5×109) per mouse intra-
peritoneal (i.p.) on day 0 of drug treatment.  
 
Treatment 
Animals were divided into five groups 
of six animals each: (Group I) normal con-
trol, received 1 % gum acacia; (Group II) 
positive control, received levamisole 
(2.5 mg/Kg body weight); (Group III) re-
ceived PB-EtAC (50 mg/Kg body weight); 
(Group IV) received PB-EtAC (100 mg/Kg 
body weight); and (Group V) received PB-
EtAC (200 mg/Kg body weight). Positive 
control, received levamisole and normal 
control mice received 1 % gum acacia ad-
ministered per oral (p.o.). The PB-EtAC 
was dissolved in 1 % gum acacia and was 
administered per oral for 14 days and the 
dose volume was 0.2 mL. 
 
Haemagglutination antibody (HA) titre  
The animals were immunized by inject-
ing 0.2 mL of 10 % of fresh SRBC suspen-
sion intraperitonially on day 0. Blood sam-
ples were collected in micro centrifuge 
tubes from individual animals by retro-
orbital plexus on day 7 for primary anti-
body titre and day 14 for secondary anti-
body titre. Serum was separated and anti-
body levels were determined by the hae-
magglutination technique (Gupta et al., 
2006). 
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DTH reaction 
PB-EtAC was administered 2 h after 
SRBC injection and once daily on consecu-
tive days. Six days later, the thickness of 
the left hind footpad was measured with a 
spheromicrometer (pitch, 0.01 mm) and 
was considered as a control. The mice were 
then challenged by injecting 20 μL of 5×109 
SRBC/mL intradermally into the left hind 
footpad. The foot thickness was measured 
again after 24 and 48 h (Bafna and Mishra, 
2006). 
 
Splenocyte proliferation assay 
Spleen collected under aseptic condi-
tions in HBSS was minced using a pair of 
scissors and passed through a fine steel-
mesh to obtain a homogeneous cell suspen-
sion and the erythrocytes were lysed with 
RBC lysis solution. After centrifugation 
(380 × g at 4 °C for 10 min), the pelleted 
cells were washed three times with PBS and 
re-suspended incomplete medium [RPMI 
1640 supplemented with 12 mM HEPES 
(pH 7.1), 0.05 mM 2-mercaptoethanol, 
100 IU/mL penicillin, 100 μg/mL strepto-
mycin, and 10 % FCS]. Cell number was 
counted with a haemocytometer by the try-
pan blue dye exclusion technique. Cell via-
bility exceeded 95 % (Wang and Li, 2002). 
To evaluate the effect of PB-EtAC on 
the proliferation of splenic lymphocytes, 
spleen cell suspension (2×106 cell/mL) was 
pipetted into 96 well plates (200 μL/well) 
and cultured at 37 °C for 72 h in a humid 
saturated atmosphere containing 5 % CO2 
in the presence of Con-A (5 μg/mL) and 
LPS 10 μg/mL). After 72 h, 20 μL of MTT 
solution (5 mg/mL) were added to each 
well and incubated for 4 h. The plates were 
centrifuged (1400 × g, 5 min) and the un-
transformed MTT was removed carefully 
by pipetting. To each well, 100 μL of a 
DMSO working solution (192 μL DMSO 
with 8 μL 1 M HCl) was added, and the ab-
sorbance was evaluated in an ELISA reader 
at 570 nm after 15 min (Khajuria et al., 
2008). 
Macrophage function assay  
(NO production) 
Immunized mice were administered 
with plant extract for 14 days. On day 14 
the mice were sacrificed and injected with 
10 mL of ice cold IRPMI medium (i.p.). 
Macrophages were collected peritonially 
after lavaging the mice using the same sy-
ringe in centrifuge tubes. The tube was cen-
trifuged at 1800 rpm for 10 min at 4 °C. 
The supernatant was discarded and the pel-
let was dissolved in RBC lysis buffer 
(2 mL), incubating the tube in ice for 5 min. 
The tube was centrifuged again for 10 min 
and the pellet was dissolved in 1 mL of 
RPMI media. The viaibility of cells was 
checked in trypan blue. The cells were cul-
tured in the U-bottomed 96 well plates. The 
plate was incubated in CO2 incubator for 
24 h. After 24 h the plate was centrifuged 
for 10 min at 2000 rpm. 100 µL of superna-
tant was collected from the plates and 
poured it in another plate in the same fash-
ion. 100 µL of Griss reagent III (Griss rea-
gent I & Griss II in 1:1 ratio) was added to 
the supernatant of each well. Thereafter 
100 µL of DMSO was added in each well 
of the standard plate containing the pellet 
and was read at 540 nm (Green et al., 1982; 
Ganju et al., 2007). 
 
In vivo carbon clearance and Candida  
albicans clearance  
Phagocytic function of the RES (reticu-
lo-endothelial system) was assayed in 
groups of 5 mice each by injecting i.v. 
160 mg/Kg body weight of 1.6 % suspen-
sion of gelatin stabilized carbon particles of 
20-25 μm size (Hudson and Hay, 1980). 
Blood samples were collected from the ret-
ro-orbital plexus immediately before and at 
various intervals between 0 and 60 min af-
ter carbon injection. An aliquot (10 μL) of 
blood samples was lysed with 2 mL of 
0.1 % acetic acid and transparency deter-
mined spectrophotometrically at a wave-
length of 675 nm (Uvikon 810, spectropho-
tometer, Kontron Ltd., Switzerland) until 
transparency equivalent to standard (origi-
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nal pre-injection blood sample) was ob-
tained as per method described by Atal et 
al. (1986). 
The peritoneal macrophages of PB-
EtAC (50, 100 and 200 mg/Kg) treated 
mice were harvested by flushing the cavity 
with 5 mL of RPMI-1640 medium, pelleted 
by centrifugation at 1100 rpm for 10 min, 
re-suspended in RPMI-1640 containing 
10 % heat activated fetal bovine serum, 
4 mM glutamine, 100 units/mL penicillin, 
100 μg/mL streptomycin and 100 mM sodi-
um pyruvate. The viable cell suspension 
(2×106 cells/mL) was allowed to adhere to 
glass slides for 2 h at 37 °C in a humidified 
CO2 incubator. The glass slides were 
washed thoroughly to remove non-adherent 
cells. 100 μL of opsonized Candida cells 
(100 °, 30 min) was then spread over the 
adherent cells. The slides were incubated 
for 15 min in a humidified CO2 incubator 
and stained with trypan–eosin after thor-
ough washing with PBS to determine the 
adherent cells containing yeast cells micro-
scopically. The number of yeast cells in-
gested per macrophage was taken as the 
phagocytic index (Freidlin et al., 1988).  
 
Determination of IFN-γ, IL-2 and IL-4 by 
the ELISA method 
Serum was collected 4 h after final oral 
administration of the alcoholic extract of 
PB-EtAC. The IFN-γ, IL-2 and IL-4 were 
measured with an enzyme linked immuno-
sorbent assay (ELISA kit, R&D Systems 
Quantikine) according to the instructions of 
the manufacturer (Farrar and Schreiber, 
1983; Beutler and Cerami, 1989). 
 
Lymphocyte phenotyping in spleen 
The spleen (1/3 of the organ) was 
placed in PBS buffer (without Mg2+ and 
Ca2+) and stored on ice prior to preparation 
of single cell suspension. Splenic erythro-
cytes were lysed with red blood cell lysis 
buffer (BD Pharmingen). Cell suspensions 
were refrigerated (4 °C) pending staining 
with antibodies. All reagents were pur-
chased from BD Pharmingen. For each 
sample, 2×106 cells were stained with con-
jugated anti-CD8 FITC and anti-CD4 PE 
antibodies. After staining with antibodies, 
cells were washed and re-suspended in PBS 
for flow cytometric analysis which was per-
formed on a FACS Calibur flow cytometer 
equipped with Cell Quest software (Becton 
Dickinson) (Gupta et al., 2006). 
 
Statistics 
Data were expressed as mean ± SEM, 
and statistical analysis was carried out us-
ing one-way ANOVA (Bonferroni correc-
tion multiple comparison test). All in ex vi-
vo experiments were carried out in tripli-
cates and represented as mean ± SEM. 
Dunnett's test was used to analyze the dif-
ferent variables in the same subject, and p 
values <0.05 have been taken as statistically 
significant. 
 
RESULTS 
HPLC fingerprinting of PB-EtAC  
The HPLC chromatogram of PB-EtAC 
is shown in Figure 1. It showed 10 peaks 
with varying retention times (2.44, 3.63, 
4.27, 6.27, 9.60, 11.92, 13.63, 18.03, 27.08 
and 34.43) including the presence of 
isoorientin (11.92); orientin (13.63) and 
isovitexin (27.08). 
 
EXCLI Journal 2014;13:137-150 – ISSN 1611-2156 
Received: November 21, 2013, accepted: February 10, 2014, published: February 17, 2014 
 
 
142 
Figure 1: HPLC fingerprinting of PB-EtAC showing presence of isoorientin (11.92); orientin (13.63) 
and isovitexin (27.08) in different Rt. The separation was carried out Eclips XBD C18 column, 4.6 × 
150 mm, 5 µm particle size, and the temperature was maintained at 25 °C.  
 
 
Effect of PB-EtAC on anti-SRBC antibody 
titre 
Anti-SRBC antibody (IgM and IgG) ti-
tres were measured in mice sera of different 
groups, collected retro-orbitally on 7 and 14 
days after immunization and treatment. An-
ti-SRBC antibody titres increased in mice 
treated with three doses of PB-EtAC (50, 
100 and 200 mg/Kg) after seven days when 
compared with control. A similar profile 
was obtained after 14 days, with IgG pre-
dominating over IgM (Figure 2). The max-
imum effect was observed at 200 mg/Kg in 
both primary and secondary antibody titre 
(p<0.01). Further decrease in dose 
(50 mg/Kg) showed a decreased response. 
Administration of levamisole (2.5 mg/Kg, 
p.o.), was used as a positive control resulted 
in a significant increase in the humoral an-
tibody titre compared with the control ani-
mals.
 
Figure 2: Antibody titres (IgM and IgG) in mice sera were measured on day 7 and day 14 after im-
munization. Data are mean ± S.E. of six animals. *P<0.05 and **P<0.01 compared with control group 
determined by one-way ANOVA (Bonferroni correction multiple comparison test). For experimental 
details refer to Materials and methods section. 
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Effect of PB-EtAC on delayed type hyper-
sensitivity (DTH) reaction in mice 
In order to assess the cell-mediated im-
mune response, DTH reaction to SRBC was 
measured as given in Figure 3, in which 
data are expressed in terms of the swelling 
of the footpad. After administration of the 
PB-EtAC (50–200 mg/Kg, p.o.), a signifi-
cant increase (p<0.01) in footpad thickness 
was found at 24 and 48 h as compared with 
the control group: maximum increase being 
observed at 200 mg/Kg. Further decrease in 
dose (50 mg/Kg) showed a decreased re-
sponse. 
 
Effect of PB-EtAC on splenocyte  
proliferation assay 
The effect of PB-EtAC on Con-A and 
LPS-stimulated splenocyte proliferation in 
immunized mice is shown in Figure 4. 
Lymphocyte proliferation was studied by 
MTT assay. PB-EtAC caused profound 
lymphocyte activation which triggered sig-
nificant (P<0.01) and concentration-de-
pendent proliferation of naive murine sple-
nocytes. Con-A (5 μg/mL) and LPS (10 μg/ 
mL) stimulated splenocyte proliferation 
was significantly enhanced by PB-EtAC 
with the maximum effect at 200 mg/Kg dose 
 
Figure 3: DTH response was determined in SRBC immunized, PB-EtAC treated mice at 24 and 48 h 
after antigen challenge. Data are mean ± S.E. of six animals. *P<0.05 and **P<0.01 compared with 
control group determined by one-way ANOVA (Bonferroni correction multiple comparison test). For 
experimental details refer to Materials and methods section. 
 
Figure 4: Influence of PB-EtAC (50–200 mg/Kg) on proliferation of T and B lymphocytes ex vivo. Mice 
were exposed to graded doses of PB-EtAC p.o. daily for 14 days. Control mice received the vehicle 
only. Splenocytes were isolated and stimulated with sub-optimal amounts of mitogens; Con A 
(5 μg/mL), LPS (10 μg/mL) for T and B cell proliferation, respectively. Cells were incubated for 72 h 
and proliferation was measured by MTT reduction assay. Splenocyte proliferation is expressed as the 
stimulation index (SI). Data are mean ± S.E. of six animals. *P<0.05 and **P<0.01 compared with con-
trol group determined by one-way ANOVA (Bonferroni correction multiple comparison test). For exper-
imental details refer to Materials and methods section. 
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and this cellular proliferation was increased 
up to two fold in Con-A and LPS treated 
cells respectively, compared to the control. 
Further decrease in dose (50 mg/Kg) 
showed a decreased response. 
 
Effect of PB-EtAC on macrophage  
function assay (NO production) 
The effect of PB-EtAC on macrophage 
function was assessed by measuring the 
amount of NO produced from peritoneal 
macrophages of PB-EtAC treated mice. 
Griess reagent was used to measure the ni-
trite levels, the stable end-product of NO 
metabolism. Macrophages were cultured in 
RPMI-FBS (10 %) with LPS (1 μg/mL) and 
contents of nitrite was measured in the su-
pernatants. The nitrite concentration was 
determined by extrapolation from a sodium 
nitrite standard curve and the results are 
expressed in μM. The effect of PB-EtAC 
(50, 100 and 200 mg/Kg) on nitric oxide 
production is shown in Figure 5. Increasing 
doses of PB-EtAC (50–200 mg/Kg) signifi-
cantly enhanced the nitrite content in peri-
toneal macrophages. The maximum effect 
was observed at 200 mg/Kg dose compared 
with the control group. 
 
Effect of PB-EtAC on carbon clearance 
and C. albicans clearance test 
Oral administration of PB-EtAC (50–
200 mg/Kg) for 5 days and 30 min prior to 
injection of colloidal carbon increased the 
clearance rate of carbon particles from 
mouse reticulo-endothelial system. A sig-
nificant increase in phagocytic index was 
obtained at all dose levels (Figure 6). Can-
dida cells were eliminated within 0.5 h 
from the peritoneal cavity of mice treated 
with PB-EtAC against 4 h in control mice. 
There was a significant clearance of C. al-
bicans in PB-EtAC treated mice as com-
pared with control mice. 
 
 
 
Figure 5: Effect of PB-EtAC (50-200 mg/Kg) on nitrite content in macrophages. Peritoneal macro-
phages were isolated from mice given graded doses of PB-EtAC for 14 days. Macrophages (3×106 
cells/well) were cultured and stimulated with LPS (1 μg/mL) for 48 h. The supernatants were used for 
nitrite assay using Griess reagent. Results are expressed in μM. Data are mean ± S.E. of six animals. 
*P<0.05 and **P<0.01 compared with control group determined by one-way ANOVA (Bonferroni cor-
rection multiple comparison test). For experimental details refer to Materials and methods section. 
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Figure 6: Effect of PB-EtAC on carbon clearance and Candida albicans clearance in mice. Phagocytic 
function of the PB-EtAC-treated macrophages was assayed in groups of 5 mice. The rate of carbon 
clearance and Candida albicans clearance, termed hereafter in the text as phagocytic index (K), was 
calculated from the slope of each time concentration curve drawn by plotting 100-mean transmittance 
values as ordinate in a semi logarithmic paper against time as abscissa. Values are means ± SE 
(n=4); *P<0.05 and **P<0.01 (control vs. PB-EtAC-treated groups; one-way ANOVA followed by Bon-
ferroni multiple comparison test). For experimental details refer to Materials and methods section. 
 
 
Effect of PB-EtAC on IFN-γ, IL-2 and  
IL-4 in mice sera by ELISA 
In order to establish that Th1 and Th2 
cytokines were involved in the immuno-
stimulatory activity of PB-EtAC, cytokine 
secretion patterns were analyzed in the sera 
of immunized mice. PB-EtAC caused a sig-
nificant (P<0.01) dose dependent up-
regulation of the Th1 (IFN-γ, IL-2) and Th2 
(IL-4) cytokines at the doses of 50, 100 and 
200 mg/Kg: maximum response being at 
200 mg/Kg dose compared with the control 
group (Figures 7a, b and c). Further de-
crease in the dose (50 mg/Kg) showed a 
decreased response. 
 
 
Figure 7a: Effect of PB-EtAC on IFN-γ production in mice sera. Serum was collected 4 h after the final 
oral administration of PB-EtAC (50, 100 and 200 mg/Kg). IFN-γ concentration was measured by en-
zyme-linked immunosorbent assay (ELISA kit, BD Opt EIA set) according to the instructions of the 
manufacturer.  
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Figure 7b: Effect of PB-EtAC on IL-2 production in mice sera. Serum was collected 4 h after the final 
oral administration of PB-EtAC (50, 100 and 200 mg/Kg). IL-2 concentration was measured by en-
zyme-linked immunosorbent assay (ELISA kit, BD Opt EIA set) according to the instructions of the 
manufacturer.  
 
 
Figure 7c: Effect of PB-EtAC on IL-4 production in mice sera. Serum was collected 4 h after the final 
oral administration of PB-EtAC (50, 100 and 200 mg/Kg). IL-4 concentration was measured by en-
zyme-linked immunosorbent assay (ELISA kit, BD Opt EIA set) according to the instructions of the 
manufacturer.  
 
Data are mean ± S.E. of six animals. *P<0.05 and **P<0.01 compared with control group determined by one-way ANOVA (Bon-
ferroni correction multiple comparison test). For experimental details refer to Materials and methods section. 
 
 
 
 
Effect of PB-EtAC on lymphocyte pheno-
typing in spleen 
The effect of PB-EtAC on the popula-
tion of cell surface markers like CD4 and 
CD8 populations was determined in spleno-
cytes prepared from spleen of mice collect-
ed after 14 days of oral treatment of PB-
EtAC. Results are presented in Figure 8. 
PB-EtAC caused a significant (p<0.01) 
dose dependent increase in both CD4 and 
CD8 population at the doses of 100 and 
200 mg/Kg: maximum response being at 
200 mg/Kg dose compared with the control 
group. 
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Figure 8: Flow cytometric analysis of the expression of co-stimulatory signal molecules in spleen-
derived macrophages. To quantify the expression of co-stimulatory molecules, 2×106 macrophages 
were stained with FITC-labeled anti-CD8 and PE-labelled anti-CD4 mAbs. Other conditions were the 
same as described in Materials and methods section. Data represented by percent CD8/CD4 positive 
cell populations of six animals.  
 
DISCUSSION 
Bamboo has been used as a food mate-
rial and the primary role of food is to pro-
vide sufficient nutrients to meet metabolic 
requirements or to modulate various phys-
iological functions that may play beneficial 
roles in some diseases (Granato et al., 
2010). To the best of our knowledge, this 
study is the first to show the immunostimu-
latory potential of bamboo. Traditionally a 
large number of plants used in medicine 
have been shown to possess immunomodu-
lating activities (Choi et al., 2004) and are 
being extensively explored for their poten-
tial in the treatment and prevention of 
chronic disease. Immunomodulatory agents 
of animal and plant origin increase the im-
mune responsiveness of the body against 
pathogen by activating immune competent 
cells (Sharma et al., 2012). There is strong 
requirement of the drugs which can boost 
immune system to combat the immunosup-
pressive consequences caused by stress, 
chronic diseases like tuberculosis, condi-
tions of impaired immune responsiveness 
(e.g. AIDS), etc. (Wagner, 1999). One of 
the most well-studied plant species in terms 
of medicinal plant is P. bambusoides, found 
widely in Asian countries including India, 
Korea, China and Japan from which the 
largest number of compounds (flavonoids, 
glycosides, saponins, tannins, proteins, car-
bohydrates, etc.) has been identified (Tomar 
et al., 2012). 
In the present study, immunomodulato-
ry potential of PB-EtAC was explored ex-
tensively on the modulation of both T and 
B cells in relation to serum immunoglobu-
lins IgM and IgG to T dependent antigen 
SRBC. Primarily, the antibody response to 
SRBC was observed by the haemagglutina-
tion titre. The augmentation of humoral an-
tibody response to T-dependent antigen 
(SRBC) reveals the increased responsive-
ness of macrophages since the antibody 
production was closely associated with the 
co-operation of macrophages, T and B lym-
phocyte responsiveness (Benacerraf, 1978). 
The T cells in turn participate in the expres-
sion of cell mediated immunity contributing 
to DTH. A DTH reaction is an expression 
of cell-mediated immunity and plays a role 
in many inflammatory disorders (Gongora 
et al., 2000). Treatment with PB-EtAC en-
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hanced the DTH reaction, as reflected by 
the increased footpad thickness compared 
to the control group, suggesting heightened 
infiltration of macrophages to the inflam-
matory site. Moreover, PB-EtAC stimulated 
phagocytosis and augmented Con-A and 
LPS induced splenocyte proliferation. 
Cytokines are major factors involved in 
regulation of the immune response to anti-
gens and infectious agents. Th1 cells are 
able to produce IL-2 and IFN-γ whereas 
Th2 cells can produce IL-4 (Villard et al., 
1999). The augmentation of T and B cells 
with PB-EtAC may be due to a cytokine-
mediated mechanism. Since IFN-γ is up 
regulated in PB-EtAC treated groups, it is 
an important immunoregulatory molecule 
which protects against viral infections, in-
duces the generation of T cells, activates 
macrophages and regulates crossly Th1 and 
Th2 cells. IFN-γ can enhance immunoregu-
latory ability. IL-4, known to activate mo-
nocytes or macrophages, is produced by T 
helper (Th2) cells or mast cells. Investiga-
tion of the balance of Th1 and Th2 cytokine 
production should be helpful to understand-
ing the outcomes of different immune re-
sponses and are clinically useful in treating 
immunologically deregulated states (Fang 
et al., 2005). PB-EtAC upregulated the pro-
duction of IL-4 with a significant release of 
IFN-γ and IL-2, thus regulating the Th1 and 
Th2 balance. 
Macrophages are important cells for the 
immune system which play an important 
role in host defense mechanisms for protec-
tion from microbial invaders. When macro-
phages are stimulated with foreign sub-
stances, a variety of cytokines and chemi-
cals are released to induce fundamental de-
fense systems. Among them, TNF-α is a 
representative cytokine secreted by macro-
phages that plays a key role in the cytokine 
network, e.g. T cell and NK cell activation 
(Tanaka et al., 1999). Also, TNF-α is a ma-
jor pro-inflammatory cytokine characteris-
tically produced at sites of inflammation by 
macrophages and is considered to help in 
eliminating certain invaders. Its levels in 
plasma are directly correlated with the abil-
ity of phagocytes to generate superoxide 
and to increment the activity of iNOS and, 
thus, NO levels (Miesel et al., 1996). Fur-
thermore, TNF-α produced by activated 
macrophages, enhances the cytotoxic action 
of macrophages. We observed that PB-
EtAC strongly augmented the release of 
nitric oxide from macrophages. Our results 
thus suggested that PB-EtAC is capable of 
stimulating immune functions of macro-
phages through increase in NO production. 
The exact mechanism by which PB-EtAC 
stimulates the macrophages and their sub-
sequent NO production could be due to 
macrophage specific TNF-α release, which 
plays a dominant role in the augmentation 
of macrophage function. Moreover, PB-
EtAC showed a significant increase in the 
phagocytic activity of macrophages against 
Candida.  
To further elucidate the mechanism of 
PB-EtAC as an immunomodulator, the ef-
fects of PB-EtAC on both CD4+ and CD8+ 
spleen T lymphocytes populations in SRBC 
immunized BALB/c mice were analyzed by 
flow cytometric assay. T cells differentiate 
into two different subsets according to their 
specific membrane molecule, that is CD4+ 
and CD8+ T lymphocytes, which play dif-
ferent roles in immunomodulation. It is well 
known that Th cells and cytotoxic T lym-
phocytes (CTLs) responses are associated 
with the enhancement of CD4+ and CD8+ 
T-lymphocytes respectively. Th cells can 
promote proliferation, maturation, and im-
munologic function of other cell types, and 
specific lymphokines secreted by Th cells 
are very important for the activities of B 
cells, macrophages, and CTLs (Zhang et al., 
2009). In contrast, CTLs are extremely im-
portant in the defense against viral infec-
tions. The results of present investigation 
revealed that the percentage of CD4+ and 
CD8+ T lymphocytes in SRBC-immunized 
mice were greatly augmented by PB-EtAC. 
The enhanced percentages of both CD4+ 
and CD8+ T lymphocytes in whole blood 
indicated that both Th and CTLs were acti-
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vated greatly by PB-EtAC. This report is 
the first to show the immunostimulatory 
potential of P. bambusoides. It provides the 
baseline information regarding the potential 
use of this plant species as an immune-
nutrition supplement. Therefore, it could be 
a drug of choice, effective in treating the 
diseases where the underlying defect is a T-
cell and B-cell deficiency or phagocytic 
dysfunction. 
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